Introduction
Crystallization is an important separation and purification process employed to produce a broad diversity of materials in the bulk, fine chemicals, food and pharmaceutical industries. 1 Crystallization can influence the performance of downstream process operations such as filtration, drying and milling.
Physical-chemical properties of the final product also depend on crystal characteristics. In the pharmaceutical industry, over 90% of the active pharmaceutical ingredients (API) are crystals of small organic molecules.
A standard crystallization procedure is the antisolvent crystallization, which involves the mixing of two miscible fluids: the solution of API and a component that reduces the solubility of API in the mixed solvent. As a result, API crystallizes out of the solution. The balance between the nucleation and crystal growth processes controls the crystal size and size distribution. 2 In industrial processes the crystal size and size distribution have to be controlled within specific limits. In antisolvent crystallization, factors controlling these parameters include supersaturation, residence time, as well as addition and mixing of antisolvent. 3 Increasing the steady state supersaturation in Mixed Suspension Mixed Product Removal (MSMPR) type crystallizers, or inlet supersaturation in a Plug Flow (PF) type crystallizers will normally move the crystal size distribution (CSD) to smaller sizes. Stahl et al. studied the crystallization of benzoic acid at various level of supersaturation in a plug flow reactor with a T mixer. 4 The weight mean size of benzoic acid decreased from 9.3 μm to 3.5 μm with increasing initial supersaturation ratio from 3.5 to 5.5. Rivera and Randolph found that the mass weighted mean size of pentaerythritol is a linear function of the initial supersaturation when crystallized in plug flow reactor. 5 The mean size of pentaerythritol decreased from 63.5 μm to 12.2 μm when the solution/ antisolvent ratio decreased from 3 to 0.25. The coefficient of variation also increased as initial supersaturation increased. Gradl et al. also reported that mean crystal size decreases with increasing supersaturation in reactive precipitation of barium sulphate in a plug flow system with a T-mixer. 6 Results of Blandin et al. on precipitation of salicylic acid with a T-mixer also showed a decrease in crystal size with increased supersaturation. 7 Crystal size distribution changes with residence time of the solution/antisolvent mixture. Raphael and Rohani studied crystallization of sunflower protein in a tubular precipitator. Experiments at various residence times were conducted adjusting the reactor length. They observed that crystals increased size with increases in the mean residence time. 8 Experimental results with barium sulphate obtained by Baldyga and Orciuch, as well as Schwarzer and Peukert also shown the effect of residence time on crystal size distribution. 9, 10 Finally, control of the addition of antisolvent has been successfully employed to obtain pharmaceutical products with uniform properties. 11, 12, 13 Lindenberg et al., 14 as well as Nagy et al., 15 have recently applied model based techniques to optimize combined cooling/antisolvent crystallization processes, resulting in superior control of the crystal size distribution.
Mixing plays an important role in crystallization. 16 In antisolvent crystallization under conditions of high supersaturation, a lack of rapid mixing in the crystallizer can drastically affect the properties of the product including crystal size distribution, morphology and purity. 17, 18, 19 If the solution is not completely mixed before the crystallization starts, the crystallization proceeds under conditions of partial segregation, which would result is wide crystal size distributions. Mahajan and Kirwan crystallized the pharmaceutical Lovastatin from methanolic solution using water as antisolvent in a rapid mixing device. 20 A broader crystal size distribution with a larger mean crystal size was obtained from the experiments with characteristic micromixing times greater than the induction time. Both mean crystal size and variance of size distribution increased with increasing the micromixing time, whereas in the experiments with characteristic micromixing times less than the induction time, there was no effect of mixing on the crystal size distribution.
A variety of systems have been proposed to ensure good mixing in antisolvent crystallization processes operated at high supersaturation to produce small crystals and narrow crystal size distributions. These systems utilize devices designed to generate rapid mixing of solution and antisolvent, and eliminate local regions of uncontrolled supersaturation. Some of these devices are:
confined impinging jets, tee-mixers, and static mixers. Confined Impinging Jet consists of two equal diameter fluid jet nozzles that collide within a small chamber, and are discharged though an outlet tube. 21 Use of confined impinging jets has been reported by Gillian to crystallize benzoic acid and voriconazole, 22 by Hacherl to precipitate Calcium Oxalate, 23 and by Mahajan and Kirwan to precipitate asparagine and lovostatin. 20 Unfortunately, it is difficult to align and maintain the alignment of the impinging fluid jet steams, the scale-up of these devices is complicated, 24 and various parts of the impinging jet apparatus tend to clog easily, making difficult the implementation of this technology for large scale production.
Static mixers are devices that promote mixing of fluids in a pipeline without moving parts. 25, 26 A common type of static mixer is the twisted-ribbon mixer known as Kenics type (Kenics KMS). This device consists of a series of alternating right and left-hand helical elements of 180° rotation, each juxtaposed at 90° As the flow profile contacts the leading edge of each helical element, it is caused to split into two and forced to follow the geometric path created by the element shape to the element preceding it. At the following element the two flows are split into two again, thus creating a geometric progression of flow division. The clockwise and counter-clockwise rotation of the elements causes the material to move from the wall to the center and from the center to the wall. After traveling through a number of these elements, the fluid is homogenized. The scale-up of mixing processes in a pipeline with static mixers is less complicated than other process configurations because of its relatively simple hydrodynamics. 27 Although static mixers have been successfully used in the plastic, polymer and oil industry for a significant length of time, literature about their application to the manufacture of pharmaceutical compounds is limited. Raphael studied the precipitation of sunflower protein in a tubular precipitator with static mixers. 8 Rivera used a static mixer for precipitation of Pentaerythritol Tetranitrate (PETN). 5 These applications limited the use of the static mixers only at the entrance of the reactor. The use of multistage addition of antisolvent (multiple injection points) to control crystal size of the crystals using static mixers has not previously been reported nor has their use along the entire reactor length. Hobbs and Muzzio reported that static mixers approaches plug flow, when the number of mixing elements is increased. 28, 29 Ideally, in a plug flow reactor there is no axial mixing, and the residence time distribution function is therefore a step function. Since a narrow residence time distribution is necessary to obtain a narrow crystal size distribution, operation in a plug flow regime is desired to reduce the variance in size distribution.
Crystallization processes can run in batch or continuous mode. Although batch is the most common method encountered in the pharmaceutical industry, continuous processing affords the advantage of enhanced reproducibility of results because all material crystallizes under uniform conditions, whereas in batch operations conditions change with time resulting in crystal characteristics difficult to control and inconsistent from batch to batch. 30 The purpose of this research work is to study a non-conventional type of continuous crystallization process operating at high supersaturation to promote the formation of small crystals. It involves the use of static mixers to reach a rapid homogeneity of solution and antisolvent, as well as to promote the operation in a plug flow regime, which lead to narrow crystal size distributions. A strategy of multiple addition points of antisolvent is evaluated to control the mean size of the crystals. The production of crystals of small size in the crystallization stage of the manufacturing process of pharmaceutical compounds is important to improve properties such as dissolution rate, bioavailability, and tableting of the drugs, and to avoid additional downstream operations such as milling to reduce the crystal size.
Although the use of tubular precipitators is well reported in the literature, 8, 31, 32, 33, 34, 35 this work focused in a particular design with multiple injection points of antisolvent to control the crystal size. 37 L-Glutamic Acid, is a small amino acid that plays an important role in the human biology. 38 The substance features two polymorphs, the metastable alpha polymorph and the stable beta form; the crystal structures are both orthorhombic, 39 with the crystal lattice parameters 
Experimental Apparatus.
A continuous plug flow system was fabricated and used in the antisolvent crystallization experiments. The modular design of this system allows it to be easily adapted to various process configurations. Figure 1 shows a schematic diagram of the experimental set-up. The system consists of four glass reactor modules. Each module consists of a core glass pipe with a volume of 76 cm 3 (600mm long, 12.7 mm internal diameter), and a jacket glass pipe (600 mm long, 35 mm diameter). Experiments can be conducted with one, two, three or four injection points of antisolvent addition. In experiments with one injection point, 100% of the antisolvent is injected at point 1 indicated in Figure 1 . In experiments with two injection points, 50% of the antisolvent is injected at point 1 and 50% at point 2. In the case of three injection points, one third of the antisolvent is injected at points 1, 2, and 3. Finally, in experiments with four injection points, 25% is injected at point 1, 25% at point 2, 25% at point 3 and 25% at point 4. Crystallization occurs inside the core pipe, and a heat exchanging fluid is circulated in the jacket to regulate to reactor temperature. The glass crystallizer allows an easy monitoring of the process at all times, to visually identify the different process stages occurring along the reactor, as well as to identify abnormal patterns in the flow. is equal to 1.5 times the tube diameter. Each element consists of a short helix, which can be rotated clockwise or counterclockwise as shown in Figure 2 . A mixing element with helix rotated clockwise is placed at an angle of 90° with respect to the next mixing element with helix rotated counterclockwise. measure a chord length, which is defined as the distance across a particle as observed by optics collecting backscattered light from a laser crossing the particle. The light scans in a circular path and as this light scans across a particle passing in front of the probe window, light is scattered in all directions.
The light scattered back towards the probe is used to measure the chord length (the product of the reflection time and the beam velocity) of the given particle. The number of such chords measured in a specific time period yields a chord length distribution. In this work, the chord length distribution provided from the FBRM probe is used as a characteristic crystal size distribution of the particle.
Raman Spectroscopy was employed to identify the polymorphic form of the crystals obtained in the plug flow experiments. A Raman Rxn1 System from Kaiser Optical System, Inc with a range from 200 to 3200 cm -1 was utilized for characterizing the crystals. Crystal morphology was observed in an Optical
Microscope model Nikon Eclipse ME 600 from Nikon Co with a Differential Interference Contrast (DIC) polarizer and magnification range from 5X to 150X.
Procedure. All experiments were conducted at 25 °C. A solution of Ketoconazole in methanol
(83 mg/ml), and water (antisolvent) were added to the glass reactor at constant flow rate using peristaltic pumps. The effect of the total flow rate on crystal size distribution of Ketoconazole was studied by running experiments at 76, 87, 101, and 122 ml/min. The ratio solution / antisolvent was 70:30 vol/vol in all experiments with Ketoconazole.
Additionally, the effect of the number of injection points of antisolvent on crystal sze distribution was evaluated with Flufenamic Acid and L-Glutamic Acid. In the first case, a solution of Flufenamic Acid in ethanol (12.4 mg/ml) with a flow rate of 100 ml/min was mixed with water (antisolvent). Experiments were conducted with 1, 2, 3, and 4 points of addition of antisolvent, corresponding to one flow of 200 ml/min, two flows of 100 ml/min, three flows of 66.67 ml/min, and four flows of 50 ml/min respectively. In the second case, a solution of L-Glutamic Acid in water (8.7 mg/ml) with a flow rate of 30 ml/min was mixed with acetone (antisolvent). Experiments were also conducted with 1, 2, 3, and 4
injection points of antisolvent corresponding to one flow of 150 ml/min, two flows of 75 ml/min, three flows of 50 ml/min, and four flows of 37.5 ml/min respectively.
The continuous crystallization process needs a period of time to reach a steady state. Frequently a period of 4 to 10 residence times is required to achieve the steady state after startup or following a serious perturbation in operating conditions. 30 The total duration of the experiments with the continuous plug flow system corresponded to 7 residence times.
A sample (approximately 5 ml) of the flowing slurry was drawn at the end of the reactor, and filtered with a 0.22 μm syringe filter (Millipore Millex Sterile Syringe Filters) to determine solute concentration. Samples of the slurry were also taken and filtered with a 0.45 μm membrane (Whatman Membrane Filter) on a Buchner funnel under vacuum and the solid phase was dried overnight at 65 °C.
Crystal size distribution of the solid product was characterized, and Raman spectra were collected to determine the polymorphic form.
Population Balance Model
The population balance approach provides a flexible framework for crystallization modeling. 40 The population balance equation for a plug flow crystallizer at steady state is expressed as:
where n (the population density) is a function of crystal size (L) and position (x) along the crystallizer, u x is the mean flow velocity, and G is the crystal growth rate. This equation assumes no radial or axial dispersion, growth rate independent of crystal size, and no significant agglomeration or breakage. The boundary condition for this partial differential equation is n(0,x)=B 0 (x)/G(x), where B 0 is the nucleation rate, and the initial condition is n(L,0)=0, that is, no seeding or solids at the entrance.
For a plug flow crystallizer the rate of depletion of solute from the solution at any location along the crystallizer must equal the rate at which the mass is gained by the solid. The general form of the mass balance is:
where C is the concentration of solute at location x, ρ s is the density of solid, and k v is the volume shape factor.
Growth rate of crystals due to deposition from the solution on the crystal surface increases with an increase in supersaturation, and is given by:
where C is the solute concentration, C s is the solubility, k g is the growth rate constant, and g is the growth rate order. As the degree of supersaturation (C-C s ) decreases along the crystallizer, so does the crystal growth rate.
The formation of new particles is modeled with a nucleation rate, which also increases with an increase in supersaturation, and may be expressed as:
where k b is the nucleation rate constant and b is the nucleation rate order. Near the entrance the nucleation rate is high and decreases as the supersaturation decreases along the crystallizer. 47 Figure 3 shows that crystals obtained at a total flow rate of 87 ml/min have a narrow size distribution. This can be explained by good mixing in a molecular level (micromixing) as well as by the constant residence time distribution expected in a plug flow regime. The insets display an optical microscope picture of the crystals at the end of the experiment.
Figure 3. Experimental Crystal Size Distribution for Ketoconazole
The effect of flow rate on the mean crystal size is presented in Figure 4 for crystallization of Ketoconazole with one point of addition of antisolvent. Figure 4 shows that a decrease in crystal size was observed as total flow rate decreased. This is in fact opposite to our immediate expectation in crystallization. We usually expect an increase in crystal size with decreased flow rate, as the residence time in the crystallizer is larger at low flow rates than at high flow rates, and therefore crystals have initial supersaturation is lower than the previous case, resulting in the formation of a less number of crystals, which consume supersaturation through crystal growth and the resultant crystal size is bigger than the previous case. For three and four injection points, a similar mechanism occurs, as the initial supersaturation is even lower and the crystals are able to grow to a bigger size. Figure 6 shows that smaller crystals with narrower size distribution were obtained when static mixers were used. As reported by Meyer, characteristic mixing time in an empty pipe is one order of magnitude bigger than the mixing time for a pipe with static mixers. 48 As a consequence, in the experiment without static mixers the nucleation and growth of Flufenamic Acid had already started before micromixing in the empty crystallizer was complete, and the crystal size Size (μm) %
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Finally the bigger peak located at the greater crystal size can be associated with the crystals nucleated before the first injection point, which had more residence time and consequently show a bigger crystal size. injection points, except that the number of small particles increased as it includes the particles nucleated in the 3rd and 4th injection points.
As shown in Figure 7 , the mean crystal size of L-Glutamic Acid was 105 μm with one injection point of antisolvent, and decrease to 67 μm with two injection points (i.e. the mean size was 105 μm when 100% and 0% of the antisolvent was added in the first and second stage respectively, and decrease to 67 μm when 50% of the antisolvent was added in the first stage, and 50% in the second stage). Additional experiments were carried out, in which 15%, 25%, and 35% of the antisolvent was added in the second Size (um) % stage (and consequently, 85%, 75%, and 65% of the antisolvent was added in the first stage). Figure 9 shows that increasing the relative amount of antisolvent added at the second stage had the effect of initially decrease and then increase the crystal size of L-Glutamic Acid. The minimum crystal size was 41 μm when 25% of the antisolvent was added in the second stage. These results suggest that there is a breakpoint at which the system changes from being a nucleation dominated process to a crystal growth dominated process. As the amount of antisolvent added at the second stage increases from 0% to 25%, the relative importance of nucleation rate over crystal growth rate increases, and thus crystal size decreases (i.e. nucleation dominated process). In contrast, an increase from 25% to 50% in the amount of antisolvent added in the second stage increases the relative importance of crystal growth rate over nucleation rate, producing an increase in crystal size (i.e. crystal growth dominated process). An experiment was carried out to evaluate the effect of flow rate in the continuous crystallization of L-Glutamic Acid. Results are shown in Figure 10 . As expected, the mean size decreased as a result of a decrease in the residence time, but interestingly the observed trend on crystal size for various points of antisolvent addition was repeated at higher flow rate (i.e. the crystal size was high for one injection point, then decreased when 2 injection points were used, and increase monotonically as the number of injection points increased). This result suggests that the observed trend depends on the initial ratio of solution to antisolvent, which was maintained constant in both experiments. Acid with one, two, three and four points of antisolvent addition are presented in Table 2 . The parameters were estimated for all experiments separately using the steady state crystal size distribution at the end of the plug flow crystallizer. To obtain an efficient optimization and accelerate convergence, the parameters k g , and k b were scaled nonlinearly, using ln(k g ), and ln(k b ) respectively. Table 1 shows estimated growth rate parameters between 8.15 x 10 -7 m/s and 14 x 10 -7 m/s, which could be explained by the higher initial relative supersaturation at which the plug flow crystallization experiments were conducted (between 2.18 and 8.58). 
where the dimensionless variables y, z, ξ , and Pe are defined as
where n is the population density, 0 0 n is the initial nuclei density, L is the crystal size, G o is the initial growth rate, τ is the residence time, x is the length along the crystallizer, x is the effective reactor length, u x is the mean flow velocity, and D is the axial diffusivity coefficient.
The dimensionless population balance equation for the crystallizer (equation 9) assumes no radial dispersion and has initial condition:
, and boundary conditions: In order to determine the extent of dispersion the plug flow crystallizer, residence time distribution (RTD) experiments were performed using a non reactive tracer method. A step response experiment was conducted in the plug flow crystallizer, and the extent of dispersion was determined in terms of the axial Peclet number (Pe), as described by Smith. 50 . It was observed that increasing the flow rate from 100 ml/min to 400 ml/min, the value of Peclet number increased from 230 to 360. This is an expected result, as the Peclet number is a measure of convection to diffusion transport rate, thus an increase in the velocity of the fluid increases the convection transport rate, leading to higher values of Pe. Using the values of Peclet number calculated from the step response experiments, the crystal size distribution of Flufenamic Acid was obtained by solving equation 9. In Figure 12 , the experimental CSD for the antisolvent crystallization of Flufenamic Acid with one point of antisolvent addition is shown together with the calculated results. It can be observed that the calculated distribution is still narrower than the experimental data. This result suggests that the RTD is not the only factor that determines the size spread of the CSD from the plug flow crystallizer. A possible explanation is that the assumption of all crystals growing at the same growth rate is not valid. Growth rate dispersion is a recognized factor that may leads to increase the broadness of CSD in continuous systems, as observed by Zumstein and Rousseau. Growth rate dispersion implies that crystals of the same size and shape grow at different rates in the same environment. 54, 55, 56, 57 Two different mechanisms that lead to growth rate dispersion have been proposed and have experimental support. 53 The random fluctuations mechanism assumes that all crystals have the same time-averaged growth rate but that individual crystals growth rates fluctuate during growth periods. Alternatively, the constant crystal growth mechanism assumes that crystals are born with an inherent constant growth rate, but the rate from crystal to crystal varies. 58 In 
where G is the mean growth rate, D G is the growth diffusivity, and L is the mean crystal size.
The model for a plug flow crystallizer with growth rate dispersion, as described in Equation 11 , was solved numerically using Euler method. The parameter Pe G was estimated by fitting simulated size distributions to experimental data, using nonlinear optimization. there is an increased interest in development of continuous crystallization processes.
